The major zinc metalloprotease of Leishmania (gp63), an important determinant of parasite virulence, is attached to the parasite surface via a glycosylphosphatidylinositol anchor. Here we report the spontaneous release of proteolytically active gp63 from a number of Leishmania isolates, causing cutaneous and visceral disease. To investigate the mechanism(s) of gp63 release, we transfected a gp63-deficient variant of Leishmania amazonensis with constructs expressing gp63 and various mutants thereof. Surprisingly, approximately half of wild type gp63 was found in the culture supernatant 12 h post-synthesis. Biochemical analysis of the extracellular gp63 revealed two forms of the protein, one that is released from the cell surface, and another, that apparently is directly secreted. Release of cell surface gp63 was significantly reduced when the proteolytic activity of the protein was inactivated by site-specific mutagenesis or inhibited by zinc chelation, suggesting that release involves autoproteolysis. The extracellular gp63 does not contain a glycosylphosphatidylinositol moiety or ethanolamine, indicating that phospholipolysis is not involved in the release process. Release of gp63 is also independent of glycosylation. The finding of proteolytically active, extracellular gp63 produced by multiple Leishmania isolates suggests a potential role of the extracellular enzyme in substrate degradation relevant to their survival in both the mammalian host and the insect vector.
A variety of microorganisms possess membrane-bound and/or secreted proteases that aid in their invasion of host tissues (1) . Similarly, invasive tumor cells possess extracellular matrix metalloproteases that enhance their metastatic potential (2, 3) . Structurally related to these is a 63-kDa surfacelocalized zinc-dependent protease (gp63 or leishmanolysin) expressed by protozoan parasites such as Leishmania, Trypanosoma, and Crithidia (4 -8) . Common features of these endoproteinases include a HEXXH-zinc binding/catalytic domain, multiple sites of N-linked glycosylation, and membrane linkage with a glycosylphosphatidylinositol (GPI) 1 anchor, all of which may contribute to posttranslationally regulate enzyme expression (9) . The finding that gp63 has an HEXXH domain and can undergo autoactivation, presumably via a cysteine switch mechanism, has led to its comparison with matrix metalloproteases (10, 11) .
Leishmania gp63 is involved in the binding of the parasite to and intracellular survival within host macrophages (5, (12) (13) (14) . Upon inoculation into the mammalian host by their sandfly vector, infective flagellated promastigotes are exposed to a variety of antimicrobial factors, some of which may be inactivated by gp63. For example, gp63 renders Leishmania resistant to complement-mediated lysis; cleavage of surface C3b enhances parasite binding to macrophage complement receptors, thereby facilitating uptake by the obligate host cell of the organism (15) . In addition, gp63 itself is a ligand for binding to host surface proteins, such as the fibronectin receptor (16 -18) . Upon macrophage binding, the parasite is phagocytized and thereafter multiplies as an intracellular amastigote form in host phagolysosomes (19) . The survival of Leishmania amazonensis in this inhospitable environment is greatly facilitated by the presence of proteolytically active gp63 (13, 14) .
Membrane association of surface ligands via GPI anchors is a common feature of the trypanosomatids (20) . Release of these GPI-anchored proteins is inducible experimentally either by transgenetic expression of GPI-phospholipase C or deletion or site-specific mutation of their GPI attachment sequences (9, 21, 22) . Release of the GPI-anchored variant surface glycoprotein (VSG) of the bloodstream African trypanosome, a spontaneous natural event during its life cycle, has also been well characterized. VSG release occurs via proteolysis during the differentiation of the bloodstream form to the insect procyclic form as well as via activation of a GPI-phospholipase during periods of cellular stress (e.g. osmotic or pH) (23) .
In this paper, we describe significant extracellular release of gp63 from Leishmania. Release apparently involves both autoproteolysis and secretion as likely mechanisms. The finding of extracellular, proteolytically active gp63 released by multiple Leishmania species may reflect a common requirement of extracellular protease for the parasite life cycle and may also contribute to disease pathogenesis.
EXPERIMENTAL PROCEDURES
Parasites-Two parasite stocks were used for the majority of these studies, an attenuated, gp63-deficient variant of L. amazonensis, designated 250 clone 1, which had been cultivated in vitro for more than 300 passages (9, 14) , and parental L. amazonensis, designated 12 clone 1, which has remained cryopreserved with minimal in vitro growth since 1980 (LV 78). The latter has been cultured less than 50 passages in vitro and is virulent both in vitro and in vivo. The gp63 deficiency of the variants consistently correlates with a decrease of in vitro and in vivo infectivity. Cloned parasites from each stock used in this study were maintained in medium 199 (M199, Invitrogen) supplemented with 10% heat-inactivated fetal bovine serum at 25°C. Recent clinical isolates of Leishmania tropica and L. infantum from endemic sites in Turkey were maintained as described above. Construction of gp63 expression plasmids and parasite transfection were performed as described previously (9) .
Immunoblot Analysis-Parasite protein lysates were analyzed by SDS-PAGE. Resolved proteins were electrophoretically transferred to nitrocellulose membranes (Schleicher & Schuell) for immunoblot analysis using polyclonal rabbit serum raised against denatured and deglycosylated gp63 purified by monoclonal affinity chromatography from L. amazonensis (5) . The secondary antibody used was horseradish peroxidase-conjugated goat anti-rabbit Fc and developed with ECL reagent (Amersham Biosciences, Inc.).
Metabolic Labeling and Immunoprecipitation-For metabolic labeling, stationary phase promastigotes were washed three times in Hanks' balanced salt solution and labeled for 30 min in Hanks' containing 100 Ci ml Ϫ1 [ 35 S]methionine/cysteine (specific activity ϭ 100 mCi mmol Ϫ1 ; PerkinElmer Life Sciences) per 10 8 cells. After labeling, cells were washed three times in excess M199 medium and resuspended in M199 containing 10-fold excess methionine/cysteine and 0.1% bovine serum albumin to a density of 3 ϫ 10 7 cells ml Ϫ1 . Cells were chased and collected by centrifugation. Under these conditions, no change in cell density was observed. Both cell pellets and conditioned medium after centrifugation were retained for further analysis. All medium samples were cleared by three rounds of centrifugation and passage through a 0.2-m filter before immunoprecipitation for 1 h at 4°C with gp63-specific antiserum at a dilution of 1:200. For collecting cell-associated gp63, cell pellets (4 ϫ 10 8 cells) were washed three times in cold phosphate-buffered saline (PBS) and lysed on ice for 30 min after the addition of 1 ml of PBS containing 0.5% Nonidet P-40. Insoluble material was removed by centrifugation at 14,000 rpm for 30 min in a microcentrifuge. The samples were thereafter processed as described for conditioned medium. Immune complexes, in each case, were collected by the addition of 50 l of 33% protein-A-Sepharose (Sigma) for 1 h at 4°C followed by three washes with 0.2 N NaCl, 0.5% Nonidet P-40, 0.1% SDS and then processed for SDS-PAGE and gel autoradiography as described previously (24) . Cell-associated and -released gp63 were assessed in the same aliquot of culture to evaluate their relative levels. The conditions for immunoprecipitation of gp63 were optimized to ensure the maximal recovery of protein (9) . [ 3 H]Ethanolamine incorporation was performed as described previously (25) , and cells and media were analyzed as described above for 35 S incorporation. GPIphospholipase C (GPI-PLC) digestions were performed essentially as described (9) . Briefly, culture supernatants from stationary phase cells were immunoprecipitated using gp63-specific antibodies covalently linked to protein-A-Sepharose using dimethylpimelimidate (Sigma). Beads with immune complexes were washed as described above and washed twice more in GPI-PLC digestion buffer (50 mM Tris-HCl, pH 8.0, 5 mM EDTA, 1% Nonidet P-40) and divided into two fractions, one treated with 200 ng of recombinant Trypanosoma brucei GPI-PLC (a gift from K. Mensa-Wilmot) and another, used as a negative control. Purified cell-derived gp63 in fresh culture medium was processed exactly as described above as a positive control. All samples were incubated for 3 h at 37°C. To test the association of extracellular gp63 with membrane vesicles, aliquots of spent medium from metabolically labeled cells were subjected to centrifugation for 1 h at 100,000 ϫ g. gp63 was immunoprecipitated from the supernatant as described above. This precipitated gp63, an uncentrifuged aliquot of the culture supernatant, and the solubilized 100,000 ϫ g pellet were analyzed by SDS-PAGE and autoradiography. For graphical representation of kinetics and quantitation, blots were analyzed by laser-scanning densitometry.
Surface Biotinylation-Parasites were washed three times with PBS, adjusted to a density of 10 8 ml Ϫ1 to which 1 ml of 0.5 mg ml Ϫ1 of EZ-Link LC-sulfo-NHS-biotin (Pierce) was mixed, and incubated for 20 min on ice. The cells were then collected by centrifugation, resuspended again in labeling solution, and incubated again for 20 min on ice. The labeling was then quenched by washing the cells three times in excess M199, and the sample was processed for gp63 analysis as described above. For zinc chelation experiments, parasites were fixed in 0.5% glutaraldehyde for 30 min on ice, washed three times in PBS, and surface-biotinylated as described above. Zinc chelation was performed by adding a stock solution of 1,10-phenanthroline to provide the various final concentrations indicated. Biotinylated molecules were collected using immobilized streptavidin (SA) as described above.
Extracellular gp63 Purification-Spent medium from cultured parasites was collected, filter-sterilized, and concentrated ϳ50-fold using a Centricon 20 concentrator. Bovine serum albumin was removed using a Hi-Trap Blue column (Amersham Biosciences, Inc.), and fractions were assessed for the presence of gp63 by Western blotting. gp63-containing fractions were pooled and subjected to anion exchange chromatography using a Hi-Trap QFF column (Amersham Biosciences, Inc.) with a continuous salt gradient of 0 -1 M NaCl. The fractions were analyzed by Western blotting with gp63-specific polyclonal serum. gp63-containing fractions were pooled and subjected to dialysis to remove excess salt before further treatment. Endoglycosidase H treatment of gp63 was performed at 37°C at pH 5.5 before SDS-PAGE electrophoresis.
Protease Assay-Spent medium samples (250 l each) from cultures of stationary phase parasites were assayed for proteolytic activity using azocasein as the substrate (26) . After incubation, each sample was diluted with 0.4 ml of PBS before the addition of 0.1 ml of ice-cold 100% trichloroacetic acid to precipitate undigested azocasein. The precipitates were removed by microcentrifugation for 2 min. Caseinolytic activity was determined by reading the absorbance of supernatants at 366 nm and expressed as g of azocasein digested per h Ϫ1 ml Ϫ1 medium. The proteolytic activity of gp63 was assessed by comparison of medium pre-and post-immunoprecipitation with gp63-specific antiserum.
RESULTS AND DISCUSSION

gp63 Is Released from Promastigotes of Different Leishmania
Species-We previously found gp63 in the culture medium of L. amazonensis transfectants expressing a mutant gp63 defective in GPI anchor addition (9) . To determine whether gp63 is normally released spontaneously by wild type parasites, recently acquired clinical isolates causing cutaneous (L. tropica EP39 -41) or visceral (L. infantum EP32) disease were tested. Our laboratory stock of wild type L. amazonensis was included for comparison. Parasites were metabolically labeled with [ 35 S]methionine/cysteine and then chased for 12-48 h with cold methionine/cysteine. gp63 and a stable cytoplasmic protein, p36 (27) , were immunoprecipitated from cell and medium fractions and analyzed by SDS-PAGE and autoradiography (Fig.  1 ). This analysis revealed substantial levels of radiolabeled gp63 in the supernatants of all promastigote cultures. Inter- estingly, radiolabeled gp63 was released by the recent clinical (EP32-14) isolates, peaking after 12 h and decreasing slightly from 24 to 48 h post-chase, probably because of degradation of the protein. The gp63 released by different isolates was 63-65 kDa in size, consistent with that seen previously (24) . Coimmunoprecipitation of all samples with an antiserum specific for a stable cytosolic protein, p36 (27) , revealed its presence only in cells (Fig. 1 , Cell, p36) and not in the medium (Fig. 1 , Medium, p36), indicating that gp63 release did not occur as a result of cell damage or death. These results demonstrate that gp63 is released from virulent, wild type Leishmania isolates. The recent isolates tested for gp63 had undergone less than five in vitro passages. The release kinetics are similar to those of our laboratory stock of virulent wild type L. amazonensis (14) . These findings together with the absence of significant gp63 release from avirulent L. amazonensis ( Fig. 2A , see the next paragraph), suggest an association of gp63 release with virulence. It is also possible that specific gp63 isoforms are selectively released reflective of their different functional roles.
Kinetics of gp63 Release and Role of Glycosylation-To investigate the mechanism of gp63 release from cultured promastigotes, we employed a gp63-deficient variant of L. amazonensis (gp63 DV ), which produces ϳ5% of the normal level of gp63 (14, 28) . Analysis of gp63 proteins expressed in transfectant gp63 DV cells from specific transgenes facilitates the analysis of protein release, because these cells otherwise release little endogenous gp63 (seen in Fig. 2A, vector) . Because glycosylation may play a role in protein trafficking and secretion (29 -31) and mutations in the glycosylation sites of gp63 lead to reduced surface expression (9), we examined the release of these mutants proteins. gp63 DV promastigotes expressing wild type gp63 (gp63 WT ) or a mutant lacking all three sites of N-linked glycosylation (gp63 DG ) (9), both, released significant amounts of gp63 into the culture supernatant ( Fig. 2A) . The kinetics of extracellular accumulation of gp63 in these cultures was determined by immunoprecipitation of cell and medium fractions of [ 35 S]methionine/cysteine pulse-labeled stationary phase promastigotes, as described. Release of gp63
WT was detected as early as 4 h post-chase, with the extracellular concentration peaking ϳ12 h post-labeling ( Fig. 2A) . gp63 DG was released with approximately the same kinetics ( Fig. 2A, gp63 DV and gp63 DG ). Because gp63 DG produced from the transgene in both cell and medium fractions has increased electrophoretic mobility, it is possible to visualize the endogenous gp63 produced by the gp63 DV cells as well ( Fig. 2) (14) . Semi-quantitative analysis of cell-associated and released gp63 revealed that ϳ60 -70% of gp63
WT and gp63 DG synthesized during the labeling period was released by 12 h of chase (Fig. 2B) . Thus, release of gp63 is not affected by its extent of glycosylation. Moreover, the extent of deglycosylation does not affect the kinetics of gp63 release. In pulse-chase experiments, the cell-associated deglycosylated mutant was apparent within 1 h post-chase and became detectable extracellularly within 4 h (Fig. 2) , similar to that observed for wild type (Figs. 2 and 3 ) and GPI-mutant gp63s (not shown). In the case of VSG (32), it has been proposed that GPI-anchoring may provide a forward targeting signal inasmuch as VSG reporters lacking GPI-anchoring motifs have slower forward movement out of the endoplasmic reticulum, although they do eventually become secreted (32) . In light of this, the at least 3 h lag time between the appearance of cell-associated gp63 and release of gp63 may be related to the absence of a GPI moiety in the latter, hastening its exit from the cell.
Multiple Modes of gp63 Release; Surface-derived gp63-At least some of the released gp63 is derived from that preexisting on the parasite surface. This was demonstrated by examining gp63 DV cells expressing gp63 WT protein that were either surface-biotinylated (Fig. 3A) or labeled with [
35 S]methionine/cysteine (Fig. 3B) . Biotinylated gp63 was increasingly released in the medium over the 48-h time period, indicating that it was derived from the parasite surface. Concurrent analysis of the release of [
35 S]methionine/cysteine-labeled gp63 over the same time period showed a peak extracellular concentration after 12 h of chase, with a minimal decline in protein levels over successive time points (Fig. 3B) . This suggests the existence of at least two pools of extracellular gp63, released with different kinetics.
Multiple Modes of gp63 Release; Secreted gp63-There are several possible explanations for increasing levels of biotinylated, extracellular gp63 in the setting of steady to decreasing amounts of radiolabeled extracellular gp63 (Figs. 2 and 3) . The simplest is that some of the extracellular gp63 is directly secreted by the parasite without first being localized at the cell surface. This interpretation is suggested by results of double labeling experiments. Wild type L. amazonensis promastigotes were first labeled with [ 35 S]methionine/cysteine, then surfacebiotinylated, and finally chased in medium for increasing time (Fig. 4) . gp63 from cell and medium fractions was isolated by immunoprecipitation or by chromatography on immobilized streptavidin for analysis, as described under "Experimental Procedures" (Fig. 4, Cell and Medium panels) . The cellular fractions contained a constant amount of radiolabeled gp63 S]methionine/cysteine followed by cold medium for the indicated times. Aliquots of culture were removed, and cell and medium fractions were separated. gp63 was immunoprecipitated from each and analyzed by SDS-PAGE and autoradiography. B, graphical representation of gp63 release. The percent of total radiolabeled gp63 that is found in the medium is presented as the ratio of protein precipitated from the medium to protein precipitated from cells ϩ medium. Background endogenous gp63 from the gp63 DV cells (vector lanes) was subtracted from that of the gp63 WT transfectants to achieve measurement of the transgene wild type cellular gp63 (gp63 WT ).
(Cell, gp63, Autorad), whereas surface-labeled gp63 steadily declined with time (Cell, gp63, SA-HRP). Analysis of the medium fraction revealed increasing accumulation of surface-released gp63 (Medium, gp63, SA-HRP) as seen in previous single-labeling experiments. Some of the biotinylated gp63 was radioactive (Medium, SA, Autorad), indicating that it acquired a surface location after biosynthesis. We also analyzed the medium after removal of biotinylated material to determine whether some of the released gp63 may be biosynthetically radiolabeled but not biotinylated (Fig. 4 , Medium Post-SA Clear). The gp63 contained in this "SA-cleared" medium did not contain any biotinylated gp63 (Medium Post-SA Clear, gp63, SA-HRP) but did contain increasing concentrations of radiolabeled, nonbiotinylated gp63 (Medium Post-SA Clear, gp63, Autorad). Because the vast majority of 35 S-labeled gp63 destined for the surface-release pathway acquires its surface location during the first 60 min of chase (data not shown), it is unlikely that the radiolabeled, nonbiotinylated gp63 seen in the bottom autoradiogram trafficked through the surface after the biotinylation step. Rather, this material was likely derived from another intracellular pool that never became localized on the surface before its release. Another less likely possibility could be that released gp63 was endocytosed by the parasites. It has recently been shown that cell surface gp63 appears to be internalized, probably during surface membrane recycling (33) . Thus, the decreasing surface-biotinylated gp63 may be reduced partially by this mechanism. Because the total biotinylated cellular gp63 fraction appears to decrease over time this would indicate that such internalized material is either degraded or released. It is also possible that a fraction of internalized surface gp63 may be secreted, accounting for some biotinylated gp63 accumulating extracellularly. Could secretion of gp63 occur simply as a result of oversaturation of the GPI-anchoring pathway during protein synthesis and maturation? Wild type Leishmania release significant amounts of gp63 (Fig. 1) . In addition, wild type L. amazonensis overexpressing transgenetically derived gp63 have increased levels of cell-associated (34) and released gp63 (not shown). If the GPI pathway were constitutively oversaturated, accounting for the natural endogenous release from the wild type cells, then one would expect only further release of gp63 in these transfectants and stable amounts of cell-associ- 35 S]methionine/cysteine, chased for 60 min in fresh medium, and surface-biotinylated. The cells were then incubated in fresh medium for varying times, and cell-and mediumassociated gp63 were purified by immunoprecipitation with gp63-specific antiserum and protein-A-Sepharose. Immunoprecipitates were analyzed by SDS-PAGE followed either by either gel autoradiography (to detect radiolabeled gp63) or by blotting with SA-HRP (to detect biotinylated gp63). Alternatively, biotinylated surface proteins were purified from the medium by SA chromatography and detected by SDS-PAGE and gel autoradiography (gp63 is the major species). Finally, medium that had been cleared of biotinylated protein by SA chromatography was subjected to gp63 immunoprecipitation followed by SA-HRP blotting (to confirm the absence of residual biotinylated gp63) and autoradiography (to detect nonbiotinylated gp63 in the medium). ated gp63. We postulate that there is a constitutive distribution of gp63 between that destined for cell membrane location and that which is released extracellularly. The released protein likely derives from both proteolytic cleavage of surface gp63 and direct secretion.
Extracellular gp63 Is Devoid of a GPI Anchor and Is Proteolytically Active-Multiple mechanisms could account for the release of gp63 from the cell surface. We first tested the possibility that extracellular gp63 was released from cell membrane sloughing or breakup of undetected dead cells in the culture. Cell culture supernatants were collected from metabolically labeled cells and subjected to a 100,000 ϫ g centrifugation for 1 h. gp63 was immunoprecipitated from equal volumes of centrifuged and uncentrifuged spent medium and from the pellet material and analyzed by SDS-PAGE and autoradiography. Equal amounts of radiolabeled gp63 were present in the supernatant fractions of both samples, whereas no gp63 was detected in the pellet, indicating that released gp63 is not associated with membrane vesicles (not shown). Another potential mechanism could involve GPI-PLC cleavage of the GPI anchor of gp63, which exposes the inositol 1,2-cyclic monophosphate epitope known as the cross-reacting determinant (35) . Such GPI-PLC activity has been reported in related parasites Trypanosoma cruzi (36) and T. brucei (37, 38) . Immunoprecipitated extracellular gp63 digested with GPI-PLC failed to react with antibodies specific to the cross-reacting determinant (CRD) epitopes in immunoblotting experiments (Fig. 5A , Medium, compare Ϫ and (ϩ), whereas purified cellular gp63, which contains an intact GPI-anchor, reacted as expected (Fig. 5A,  Cell) . This indicates that released gp63 lacks a GPI anchor. Monoclonal antibody 6H12, initially used to purify gp63 from L. amazonensis (5) , is specific for gp63 containing the GPI anchor. 2 We used this reagent to indirectly test extracellular gp63 for the presence of a GPI anchor. Control immunoprecipitations using polyclonal serum indicate the presence of extracellular gp63 from metabolically labeled Leishmania (Fig. 5B, gp63 Poly ) from either transfectants (gp63 DV Cells) expressing the wild FIG. 5 . Released gp63 lacks a GPI anchor. A, cell-and mediumassociated gp63 was immunoprecipitated (IP) with gp63-specific antiserum digested (ϩ) or not digested (Ϫ) with GPI-PLC and analyzed by immunoblot analysis with gp63-or cross-reacting determinant (CRD)-specific antibodies. B, stationary phase, gp63-deficient variant promastigotes expressing wild type gp63 (gp63 WT ) or a gp63 point mutant defective in GPI addition (gp63 N577L ) was metabolically labeled with [ 35 S]methionine/cysteine. Media derived from these cells were immunoprecipitated with gp63-specific polyclonal antiserum (gp63 Poly ) or monoclonal antibody 6H12, which is specific for a form of gp63 containing a GPI anchor. amazonensis promastigotes were surface-biotinylated and then chased in medium for 12 h in the absence (0) or presence of 10 and 25 mM 1,10-phenanthroline. gp63 was then immunoprecipitated from the medium and analyzed by SDS-PAGE and immunoblotting with SA-HRP (left panel). In a separate experiment, the kinetics of surface release were examined by analyzing gp63 release after 1 and 12 h of chase in the presence of 0 or 25 mM 1,10-phenanthroline (OP) as indicated (middle and right panels). B, stationary phase, gp63-deficient L. amazonensis promastigotes expressing either wild type gp63 or a gp63 point mutant deficient in protease activity addition (E265D) were lightly fixed with glutaraldehyde, surface-biotinylated, washed, and incubated in medium for 24 h. gp63 was immunoprecipitated from the medium and analyzed by immunoblotting with SA-HRP (left panel). Living promastigotes were analyzed in a similar manner 12 and 18 h after surface biotinylation, with cell-associated gp63 purified also as a control (right panels). type gp63 (gp63 WT ) or the gp63 mutant in the GPI addition site (gp63 N577L ). The monoclonal antibody failed to immunoprecipitate extracellular gp63 from the same supernatants (Fig. 5B,  gp63 GPI ). Together these data support the idea that extracellular gp63 lacks a GPI anchor. Alternatively, released gp63 could possess a GPI anchor either resistant to GPI-PLC digestion, as seen in T. brucei (39) , and/or not reactive with the antibody. To test if released gp63 had received a GPI anchor during its biosynthesis, we examined the incorporation of ethanolamine, which covalently links the GPI moiety with the carboxyl group to the C-terminal amino acid of the protein. Wild type L. amazonensis (Fig. 6, WT Cells) N577L mutant was completely released into the culture supernatant as was previously shown (9) . Ethanolamine was incorporated in the cellular gp63 fractions of all cell types, indicating the presence of the ethanolamine bridge linking the protein to the GPI anchor (Fig. 6, [ 3 H]Etn, Cell). gp63 immunoprecipitated from the supernatant was ϳ3-5-fold less in the deficient variants expressing the wild type gp63 than the GPI addition mutant or untransfected wild type L. amazonensis (Fig. 6, [ 35 S]Met/Cys, Medium). Ethanolamine incorporation could not be detected in the released gp63 (Fig. 6,  [  3 H ]Etn, Medium) even after prolonged exposure of the film up to 1 month (not shown). These data further show that released gp63 contains neither a GPI anchor nor an ethanolamine molecule, ruling out the possibility that it was released by GPI-phospholipolysis.
Finally, cell culture supernatants were found to contain proteolytic activity. Culture supernatants from transfectants containing either vector alone (Fig. 7, Vector) or those expressing wild type gp63 (gp63, Pre-IP) were assessed for caseinolytic activity. The latter had approximately 10-fold higher levels of proteolytic activity. This activity is gp63-specific, since the caseinolytic activity in the medium from transfectants could be removed by immunoprecipitation with anti-gp63 antiserum (Fig. 7, compare gp63 , Pre-and Post-IP). Taken together, these data show that extracellular gp63 is soluble, proteolytically active, and devoid of a GPI anchor. The finding that gp63 is released naturally from Leishmania species is surprising, since the molecule is an abundant membrane protein linked to the surface via a GPI anchor. Release of GPI-linked surface molecules has been reported in the trypanosomatid protozoa. T. brucei VSG can be shed by two mechanisms. First, it can be proteolytically cleaved from the surface of bloodstream parasites upon their differentiation into the procyclic forms (40) . Interestingly, a zinc-dependent metalloprotease has been implicated in this process, and a likely candidate is a gp63 homologue (32) . VSG can also be released by GPI-PLC-mediated cleavage of its GPI anchor, the stimulus for which may involve multiple triggers such as osmotic stress, trypsin digestion, or changes in pH (23) .
Proteolytic Cell Surface Release of gp63-gp63 release from the cell surface may result from proteolytic cleavage, possibly autoproteolysis. Surface-biotinylated parasites were assessed for their ability to release gp63 in the presence of increasing amounts of the zinc chelator, 1,10-phenanthroline, a well known inhibitor of gp63 proteolytic activity (13) . Because this compound is toxic to cells during the incubation time frame used, we chose to use lightly glutaraldehyde-fixed cells in which gp63 was still proteolytically active on the surface (13, 26) . We performed Western blot analysis of immunoprecipitated gp63 from the supernatants of surface-biotinylated, fixed wild type Leishmania (Fig. 8) . The amount of gp63 released was diminished to ϳ50% in the presence of 10 mM chelator and is barely detectable in the presence of 25 mM chelator (Fig. 8A) . Further increases of the concentration of chelator resulted in precipitation of the inhibitor and cells. The kinetics of gp63 release from parasites over a 12-h period was tested in the presence of 25 mM chelator. Under these conditions, the release of biotinylated gp63 was reduced by ϳ7-fold. These results further show that the release is a zinc-dependent process (Fig.  8A, right panels) .
To more directly test the autoproteolytic hypothesis, transfectants expressing surface-localized wild type gp63 (gp63 WT ) and those expressing a site-specific mutant in the active site of the enzyme (gp63 E265D ) (9) were compared for their capacity to release surface gp63. Using both fixed and live parasites, quantitatively less surface-biotinylated gp63 was released from transfectants expressing the proteolytically inactive mutant (Fig. 8B) . This further indicates that the release of gp63 from the cell surface is mediated by gp63 autoproteolysis but does not fully exclude the possibility that another protease or an unrelated process dependent upon divalent cations may be involved. In a similar fashion, the GPI-linked matrix metalloprotease, MMP-17, has been shown to be released extracellularly from transfected mammalian cells by matrix metalloproteinase activity (41) . Whether this is an autoproteolytic event is not known.
We purified extracellular gp63 using anion exchange chromatography and compared its electrophoretic mobility with that of cell-associated gp63 (Fig. 9) . Purified extracellular gp63 (UT, M) is composed of two predominant forms of ϳ63 (a) and 59 kDa (c), whereas cellular gp63 (UT, C) is composed of one predominant form of 63 kDa. Endoglycosidase H treatment of cellular gp63 reduces the size of the protein to 61 kDa (b) consistent with the loss of N-linked glycans. Endoglycosidase treatment of extracellular gp63 produces two bands of ϳ61 (b) and 59 kDa (c). The 61-kDa protein probably represents fulllength, deglycosylated gp63, whereas the smaller, 59-kDa protein has likely undergone proteolysis and is devoid of N-glycans. The substrate cleavage site specificity of gp63 is not known. Peptide bond cleavage has been noted to occur Nterminal of hydrophobic residues at the P1Ј position with basic residues at P2Ј and P3Ј (42) or at serine or threonine residues (43) . The gp63 sequence between the third glycosylation site and the GPI addition site contains one serine adjacent to a threonine residue (at positions 540 and 541 in the L. amazonen- FIG. 9 . Size differences among cell-associated and extracellular forms of gp63. gp63 purified from the medium (M) of cultured parasites or from the cell surface (C) was analyzed by SDS-PAGE before (untreated, UT) and after endoglycosidase H (Endo H) treatment. a, the 63-kDa gp63 form present in both cellular and medium fractions before endoglycosidase H treatment; b, the 61-kDa gp63 form present in both cellular and medium preparations after endoglycosidase H treatment; c, 59-kDa gp63 form present in the medium-derived gp63 both before and after endoglycosidase H treatment.
sis sequence) and downstream serine (at position 543) and threonine (position 553) residues, which represent potential autocleavage sites.
The collective results shown in this paper allow us to develop a representation of the proposed pathways of gp63 release (Fig. 10) . Both follow the classic secretory pathway with routing of gp63 from the endoplasmic reticulum to the Golgi network and then into the flagellar pocket. Vesicles containing both membrane-bound and free gp63 fuse with flagellar pocket membrane, with free gp63 thereafter released extracellularly. Membrane-bound gp63 is located throughout the external cell membrane, and a proportion of this is released directly via zinc/proteolysis. We have documented the significant release of active gp63, a metalloprotease with broad substrate specificity, from the human pathogen Leishmania. The membrane-bound form of gp63 has been shown to be important for parasite virulence, being involved in the evasion of complement-mediated lysis, macrophage attachment, and intracellular survival of parasites. A myriad of functions can be hypothesized for an extracellularly released metalloprotease with broad substrate specificity. gp63 digests gelatin and fibrinogen (9, 44) and, thus, can be envisioned to play a role in the degradation of extracellular matrix proteins by parasites after their inoculation by the insect vector. This function may serve to allow greater local mobility of invading parasites, enhancing their capacity to bind to and parasitize host macrophages. Extracellular gp63 could allow parasites to evade a variety of anti-microbial factors in the extracellular environment, such as complement (18, 45) . It will be of interest to determine the capacity of amastigotes to release gp63, possibly influencing macrophage function or escape of the organism. Furthermore, within the sandfly vector, release of extracellular gp63 from promastigotes could enhance the hydrolysis of protein substrates and play a nutritional and/or protective role (6) . We are currently testing the potential role(s) of gp63 in these processes. FIG. 10 . Hypothetical model of release/secretion of gp63. The two mechanisms of gp63 release identified in this report are shown. GPI-anchored gp63 may be released from the cell surface by autoproteolytic cleavage N-terminal to the GPI addition site. Alternatively, unmodified gp63 may be directly secreted via vesicular trafficking through the flagellar pocket.
